Produktinformation
A 357300 is a novel drug that has been shown to be effective in treating bowel diseases. The drug's mechanism of action is not yet fully understood, but it has been shown to reduce pro-inflammatory cytokines, such as tumor necrosis factor (TNF), and increase anti-inflammatory cytokines, such as IL-10. A 357300 is also thought to inhibit the production of methionine aminopeptidase, which is an enzyme that degrades the amino acid methionine. This leads to higher levels of methionine in the gut, which activates a type of immune cell called a macrophage. Activated macrophages release nitric oxide (NO), which can help treat bowel disease by reducing inflammation and increasing blood flow in the gut. A 357300 has also been found to reduce pain in rats with inflammatory bowel disease by blocking nerve signals from reaching the brain through activation of calcium channels.
A 357300 has not yet been
Chemische Eigenschaften
Technische Anfrage zu: 3D-UPA35807 A 357300
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
